Comparison Between Bupivacaine Extended-Release Liposome Injection (Exparel) Versus Bupivacaine With Dexamethasone in Transversus Abdominis Plane Block: A Prospective Randomized Controlled Trial

Trial Profile

Comparison Between Bupivacaine Extended-Release Liposome Injection (Exparel) Versus Bupivacaine With Dexamethasone in Transversus Abdominis Plane Block: A Prospective Randomized Controlled Trial

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 13 Aug 2017

At a glance

  • Drugs Bupivacaine (Primary) ; Bupivacaine; Dexamethasone
  • Indications Postoperative pain
  • Focus Therapeutic Use
  • Acronyms TAPBLOCK
  • Most Recent Events

    • 25 Apr 2017 Status changed from recruiting to discontinued.
    • 06 Sep 2016 Planned End Date changed from 1 Jul 2016 to 1 Jul 2017.
    • 06 Sep 2016 Planned primary completion date changed from 1 Jul 2016 to 1 Jul 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top